Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 313,847
  • Shares Outstanding, K 18,975
  • Annual Sales, $ 62,660 K
  • Annual Income, $ -29,040 K
  • 60-Month Beta 2.87
  • Price/Sales 6.07
  • Price/Cash Flow N/A
  • Price/Book 10.84
Trade STIM with:

Options Overview

Details
  • Implied Volatility 75.75%
  • Historical Volatility 97.30%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 250.23% on 10/12/20
  • IV Low 75.75% on 03/02/21
  • Put/Call Vol Ratio 1.00
  • Today's Volume 68
  • Volume Avg (30-Day) 149
  • Put/Call OI Ratio 1.90
  • Today's Open Interest 758
  • Open Int (30-Day) 1,844

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.25
  • Number of Estimates 2
  • High Estimate -0.19
  • Low Estimate -0.30
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +39.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.21 +14.99%
on 03/02/21
21.04 -33.27%
on 02/16/21
-1.73 (-10.97%)
since 02/02/21
3-Month
7.75 +81.16%
on 12/03/20
22.43 -37.41%
on 01/22/21
+6.20 (+79.08%)
since 12/02/20
52-Week
1.25 +1,023.20%
on 03/18/20
22.43 -37.41%
on 01/22/21
+11.10 (+377.55%)
since 03/02/20

Most Recent Stories

More News
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 24.00% and 2.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

STIM : 14.41 (-12.88%)
Neuronetics: 4Q Earnings Snapshot

MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Tuesday reported a loss of $3.7 million in its fourth quarter.

STIM : 14.41 (-12.88%)
Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric...

STIM : 14.41 (-12.88%)
Neuronetics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 2, 2021 / Neuronetics, Inc. (NASDAQ:STIM) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 2, 2021 at 8:30 AM Eastern...

STIM : 14.41 (-12.88%)
Neuronetics (STIM) Soars 6.5%: Is Further Upside Left in the Stock?

Neuronetics (STIM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the...

STIM : 14.41 (-12.88%)
NeuroStar(R) Advanced Therapy Outcomes Registry Clinical Data Published in Brain Stimulation Validates Depression Treatment Protocols

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric...

STIM : 14.41 (-12.88%)
Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric...

STIM : 14.41 (-12.88%)
Neuronetics Announces Strategic Leadership Promotions to Support Future Growth

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric...

STIM : 14.41 (-12.88%)
Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric...

STIM : 14.41 (-12.88%)
Neuronetics Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Neuronetics, Inc. (NASDAQ: STIM) (the "Company"), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who...

STIM : 14.41 (-12.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics,...

See More

Key Turning Points

3rd Resistance Point 18.22
2nd Resistance Point 17.58
1st Resistance Point 17.06
Last Price 14.41
1st Support Level 15.90
2nd Support Level 15.25
3rd Support Level 14.73

See More

52-Week High 22.43
Last Price 14.41
Fibonacci 61.8% 14.34
Fibonacci 50% 11.84
Fibonacci 38.2% 9.34
52-Week Low 1.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar